Association of Gestational Cardiovascular Health With Pregnancy Outcomes

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age20-49
SponsorWomen's Hospital School Of Medicine Zhejiang University

About this trial

Pregnancy is a critical period for cardiovascular health risk assessment and interventions to reduce the incidence of cardiovascular disease in both mother and child generations. Recently, the American Heart Association proposed the latest cardiovascular health assessment indicator "Life's Essential 8". However, there is still a lack of application data for pregnant women. This project intends to explore the application potential of Life's Essential 8 in cardiovascular health assessment of pregnant women and establish appropriate gestaional cardiovascular health standards.

Eligibility criteria

Qualifiers

Maternal age: 20-49 years;

Natural conception;

Single pregnancy;

Plan to have routine prenatal examinations and give birth in the research center;

Disqualifiers

Have diseases that affect metabolic function or even threaten the life of the mother and fetus before pregnancy;

Assisted reproduction;

Multiple pregnancy;

Fetus has a known deformity or genetic defects;

Trial design

Treatments tested in this trial

  • Questionnaire survey and specimen collection

Treatment groups

No treatment groups listed